Sphera Funds Management Ltd. Gamida Cell Ltd. Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$5.85 - $8.33 $1.04 Million - $1.49 Million	-178,450 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.8 - $12.43 $1.08 Million - $1.72 Million	138,450 Added 346.13%	178,450 $1.44 Million
Q4 2020 Feb 16, 2021	BUY	$4.07 - $11.0 $162,800 - $440,000	40,000 New	40,000 $336,000

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.